The Induction of heme oxygenase 1 decreases painful diabetic neuropathy and enhances the antinociceptive effects of morphine in diabetic mice
| Autor: | Mireia Carcolé, Sergi Leánez, Olga Pol, Sílvia Castany |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Male lcsh:Medicine Nitric Oxide Synthase Type II Protoporphyrins Pharmacology Neuropathic pain 0302 clinical medicine Diabetes mellitus Diabetic Neuropathies Sciatic nerves lcsh:Science Analgesics Spinal cord Multidisciplinary CD11b Antigen biology Morphine COPP Sciatic Nerve Nitric oxide synthase Nociception Allodynia Hyperalgesia Anesthesia Enzyme Induction Systemic administration medicine.symptom medicine.drug Research Article Metalloporphyrins Blotting Western Diabetes Mellitus Experimental 03 medical and health sciences medicine Animals Analysis of Variance business.industry lcsh:R Streptozotocin CD11c Antigen Neuropathy Heme oxygenase Mice Inbred C57BL 030104 developmental biology biology.protein lcsh:Q business 030217 neurology & neurosurgery Heme Oxygenase-1 |
| Zdroj: | Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona PLoS ONE PLoS ONE, Vol 11, Iss 1, p e0146427 (2016) PLoS One r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname |
| ISSN: | 1932-6203 |
| Popis: | Painful diabetic neuropathy is a common complication of diabetes mellitus which is poorly controlled by conventional analgesics. This study investigates if treatment with an heme oxygenase 1 (HO-1) inducer, cobalt protoporphyrin IX (CoPP), could modulate the allodynia and hyperalgesia induced by diabetes and enhanced the antinociceptive effects of morphine. In a diabetic mice model induced by the injection of streptozotocin (STZ), we evaluated the antiallodynic and antihyperalgesic effects produced by the intraperitoneal administration of 5 and 10 mg/kg of CoPP at several days after its administration. The antinociceptive actions produced by the systemic administration of morphine alone or combined with CoPP were also evaluated. In addition, the effects of CoPP treatment on the expression of HO-1, the microglial activation marker (CD11b/c), the inducible nitric oxide synthase (NOS2) and mu-opioid receptors (MOR), were also assessed. Our results showed that the administration of 10 mg/kg of CoPP during 5 consecutive days completely blocked the mechanical and thermal hypersensitivity induced by diabetes. These effects are accompanied by the increased spinal cord, dorsal root ganglia and sciatic nerve protein levels of HO-1. In addition, the STZ-induced activation of microglia and overexpression of NOS2 in the spinal cord were inhibited by CoPP treatment. Furthermore, the antinociceptive effects of morphine were enhanced by CoPP treatment and reversed by the administration of an HO-1 inhibitor, tin protoporphyrin IX (SnPP). The spinal cord expression of MOR was also increased by CoPP treatment in diabetic mice. In conclusion, our data provide the first evidence that the induction of HO-1 attenuated STZ-induced painful diabetic neuropathy and enhanced the antinociceptive effects of morphine via inhibition of microglia activation and NOS2 overexpression as well as by increasing the spinal cord levels of MOR. This study proposes the administration of CoPP alone or combined with morphine as an interesting therapeutic approach for the treatment of painful diabetic neuropathy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|